Summary

The global vascular closure devices market is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 7.0% during the forecast period. The growth in this market can be attributed to a large number of approvals for vascular closure devices, high prevalence of cardiovascular diseases, increasing prevalence of obesity, increasing focus of market players on large-bore vascular closure devices, growing geriatric population, favorable reimbursement scenario for interventional radiology procedures, and rising focus on effective blood loss management in patients during surgeries. Emerging markets providing growth opportunities for market players and growth in the number of hospitals & surgical centers are expected to offer strong growth opportunities for players in the market. In contrast, the need for highly skilled professionals, risks associated with vascular closure devices, and stringent regulatory framework may challenge market growth to a certain extent. The vascular closure devices market is segmented based on type, access, procedure, and region.

“Passive approximators segment is expected to dominate the market during the forecast period.”

Based on type, the vascular closure devices market is segmented into passive approximators, active approximators, and external hemostatic devices. Passive approximators account for the largest share of the vascular closure devices market. The large share of this segment can be attributed to the increasing number of approvals for vascular closure devices and the wide range of advantages associated with these devices, such as ease of use and reduced complication rate in patients.

“Radial access segment to dominate the market during the forecast period.”

Based on access, the vascular closure devices market is segmented into radial access and femoral access. The femoral access segment commanded the largest share of the vascular closure devices market. . The large share of this segment can be attributed to the advantages of femoral access, such as better patient comfort, cost-effectiveness, and reduced hospitalization time.

“Interventional cardiology segment to dominate the market during the forecast period.”

Based on procedure, the vascular closure devices market is segmented into interventional cardiology procedures and interventional radiology/vascular surgery. Interventional cardiology for the largest share of the vascular closure devices market. The large share is attributed to the diagnosis and treatment of numerous cardiovascular disorders due to advancements in angioplasty and cardiac stenting and the growing prevalence of cardiac disorders globally.

“North America will dominate the market during the forecast period.”

The global vascular closure devices market is segmented into North America (the US and Canada), Europe (E-3, and the Rest of Europe), Asia Pacific, and Rest of World. In 2020, North America dominated the global vascular closure devices market, followed by Europe. The large share of the North American market can be attributed to the rising prevalence of cardiovascular diseases, the growing trend of one-day surgeries for vascular procedures, increasing research and clinical trials for vascular closure devices in the US, the increasing number of cardiac arrest cases, and the long waiting periods for cardiac surgeries (which encourage the adoption of minimally invasive procedures) in Canada.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type - Tier 1: 52%, Tier 2: 30% and Tier 3: 18%
• By Designation - C-level: 45%, D-level: 30%, and Others: 25%
• By Region - North America: 36%, Europe: 24%, Asia Pacific: 29%, and Rest of World: 11%

List of Companies Profiled in the Report
• Terumo Corporation (Japan)
• Abbott (US)
• Cardinal Health (US)
• Cardiva Medical, Inc. (US)
• Medtronic Plc (Ireland)
• Morris Innovative, Inc. (US)
• Teleflex Incorporated (US)
• Merit Medical Systems, Inc. (US)
• Vasorum Ltd. (Ireland)
• TZ Medical, Inc. (US)
• Vivasure Medical Ltd. (Ireland)
• Tricol Biomedical (US)
• Scion Biomedical (US)
• Advanced Vascular Dynamics (US)
• Marine Polymer Technologies, Inc. (US)
• Transluminal Technologies (US)
• Rex Medical (US)
• Meril Life Sciences Pvt. Ltd. (India)
• Medas USA (US)
• Vygon Company (France)

Research Coverage:
This report provides a detailed picture of the global vascular closure devices market. It aims at estimating the size and future growth potential of the market across different segments, such as type, access, procedure and region. The report also analyzes factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total vascular closure devices market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on vascular closure devices offered by the top 20 players in the vascular closure devices market. The report analyses the vascular closure devices market by type, access, procedure and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various vascular closure devices across key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vascular closure devices market.

• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the vascular closure devices market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 24
1.3 MARKET SCOPE 25
FIGURE 1 VASCULAR CLOSURE DEVICES MARKET SEGMENTATION 25
1.3.1 YEARS CONSIDERED FOR THE STUDY 25
1.4 CURRENCY 26
1.5 STAKEHOLDERS 26
1.6 SUMMARY OF CHANGES 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
FIGURE 2 RESEARCH DESIGN 27
2.2 SECONDARY DATA 28
2.2.1 SECONDARY SOURCES 29
2.3 PRIMARY DATA 30
FIGURE 3 PRIMARY SOURCES 30
2.3.1 KEY DATA FROM PRIMARY SOURCES 31
2.3.2 KEY INDUSTRY INSIGHTS 32
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 33
2.4 MARKET SIZE ESTIMATION 33
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 34
2.4.1 GROWTH FORECAST 35
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 35
FIGURE 7 TOP-DOWN APPROACH 36
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 37
FIGURE 8 DATA TRIANGULATION METHODOLOGY 37
2.6 MARKET SHARE ANALYSIS 38
2.7 ASSUMPTIONS FOR THE STUDY 38
2.7.1 COVID-19-SPECIFIC ASSUMPTIONS 39
2.8 LIMITATIONS 39
2.9 RISK ASSESSMENT 40
2.10 COVID-19 ECONOMIC ASSESSMENT 40
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 41
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 41
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 42
3 EXECUTIVE SUMMARY 43
FIGURE 11 VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 43
FIGURE 12 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021 VS. 2026 (USD MILLION) 44
FIGURE 13 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021 VS. 2026 (USD MILLION) 44
FIGURE 14 VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 45
4 PREMIUM INSIGHTS 46
4.1 VASCULAR CLOSURE DEVICES MARKET OVERVIEW 46
FIGURE 15 LARGE NUMBER OF APPROVALS FOR VASCULAR CLOSURE DEVICES TO DRIVE MARKET GROWTH 46
4.2 VASCULAR CLOSURE DEVICES MARKET, BY TYPE (2021–2026) 47
FIGURE 16 PASSIVE APPROXIMATORS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 47
4.3 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET,
BY TYPE AND COUNTRY (2020) 48
FIGURE 17 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN VASCULAR CLOSURE DEVICES MARKET IN 2020 48
4.4 VASCULAR CLOSURE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 49
FIGURE 18 US TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
FIGURE 19 VASCULAR CLOSURE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
5.2 MARKET DYNAMICS 51
5.2.1 DRIVERS 51
5.2.1.1 Growing approvals of vascular closure devices 51
TABLE 1 APPROVALS OF VASCULAR CLOSURE DEVICES 51
5.2.1.2 High prevalence of cardiovascular diseases 51
5.2.1.3 Increasing prevalence of obesity 52
5.2.1.4 Increasing focus of market players on large-bore vascular closure devices 52
5.2.1.5 Growing geriatric population 52
5.2.1.6 Favorable reimbursement scenario for interventional radiology procedures 53
TABLE 2 REIMBURSEMENTS FOR INTERVENTIONAL RADIOLOGY PROCEDURES IN THE US 53
5.2.1.7 Rising focus on effective blood loss management in patients during surgeries 54
5.2.1.8 Increasing investments, funds, and grants for research on vascular devices 54

5.2.2 RESTRAINTS 54
5.2.2.1 Increasing preference for interventional procedures using radial artery access 54
5.2.2.2 High cost of vascular closure devices 55
5.2.2.3 Product recalls and failures 55
TABLE 3 RECENT RECALLS OF VASCULAR CLOSURE DEVICES 55
5.2.3 OPPORTUNITIES 56
5.2.3.1 Emerging markets providing growth opportunities for market players 56
5.2.3.2 Growth in the number of hospitals & surgical centers 56
5.2.4 CHALLENGES 56
5.2.4.1 Need for highly skilled professionals 56
5.2.4.2 Risks associated with vascular closure devices 57
5.2.4.3 Stringent regulatory frameworks 57
5.3 COVID-19 IMPACT ON THE VASCULAR CLOSURE DEVICES MARKET 58
6 VASCULAR CLOSURE DEVICES MARKET, BY TYPE 60
6.1 INTRODUCTION 61
TABLE 4 VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION) 61
TABLE 5 VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 61
6.2 PASSIVE APPROXIMATORS 62
TABLE 6 PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION) 62
TABLE 7 PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION) 62
TABLE 8 PASSIVE APPROXIMATORS MARKET, BY REGION, 2017–2020 (USD MILLION) 63
TABLE 9 PASSIVE APPROXIMATORS MARKET, BY REGION, 2021–2026 (USD MILLION) 63
6.2.1 COLLAGEN PLUGS 63
6.2.1.1 Growing number of approvals for collagen-based vascular closure devices to drive market growth during the forecast period 63
TABLE 10 COLLAGEN PLUGS MARKET, BY REGION, 2017–2020 (USD MILLION) 64
TABLE 11 COLLAGEN PLUGS MARKET, BY REGION, 2021–2026 (USD MILLION) 64
6.2.2 SEALANT OR GEL-BASED DEVICES 65
6.2.2.1 Sealant or gel-based devices to register the highest growth rate during the forecast period 65
TABLE 12 SEALANT OR GEL-BASED DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 65
TABLE 13 SEALANT OR GEL-BASED DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 66
6.2.3 COMPRESSION ASSIST DEVICES 66
6.2.3.1 Compression assist devices do not leave behind any foreign body in the tissue artery—a major advantage of these devices 66
TABLE 14 COMPRESSION ASSIST DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 66
TABLE 15 COMPRESSION ASSIST DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 67
6.3 ACTIVE APPROXIMATORS 67
TABLE 16 ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION) 67
TABLE 17 ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION) 68
TABLE 18 ACTIVE APPROXIMATORS MARKET, BY REGION, 2017–2020 (USD MILLION) 68
TABLE 19 ACTIVE APPROXIMATORS MARKET, BY REGION, 2021–2026 (USD MILLION) 68
6.3.1 SUTURE-BASED DEVICES 69
6.3.1.1 Increasing applications of suture-based devices to
favor market growth 69
TABLE 20 SUTURE-BASED ACTIVE APPROXIMATORS MARKET, BY REGION,
2017–2020 (USD MILLION) 69
TABLE 21 SUTURE-BASED ACTIVE APPROXIMATORS MARKET, BY REGION,
2021–2026 (USD MILLION) 70
6.3.2 CLIP-BASED DEVICES 70
6.3.2.1 Growing innovation in the field of clip-based devices to aid market growth 70
TABLE 22 CLIP-BASED ACTIVE APPROXIMATORS MARKET, BY REGION,
2017–2020 (USD MILLION) 71
TABLE 23 CLIP-BASED ACTIVE APPROXIMATORS MARKET, BY REGION,
2021–2026 (USD MILLION) 71
6.4 EXTERNAL HEMOSTATIC DEVICES 71
6.4.1 RISING ADOPTION OF MINIMALLY INVASIVE THERAPEUTIC PROCEDURES TO DRIVE MARKET GROWTH 71
TABLE 24 EXTERNAL HEMOSTATIC DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 72
TABLE 25 EXTERNAL HEMOSTATIC DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 72
7 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS 73
7.1 INTRODUCTION 74
TABLE 26 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION) 74
TABLE 27 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION) 74
7.2 FEMORAL ACCESS 75
7.2.1 ADVANTAGES ASSOCIATED WITH FEMORAL ACCESS, SUCH AS GREATER COMFORT LEVEL FOR PATIENTS AND REDUCED COST OF HOSPITALIZATION, TO DRIVE MARKET GROWTH 75
TABLE 28 FEMORAL ACCESS: RESEARCH STUDIES 75
TABLE 29 FEMORAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017–2020 (USD MILLION) 76
TABLE 30 FEMORAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION) 76
7.3 RADIAL ACCESS 77
7.3.1 TRANSRADIAL APPROACH REDUCES VASCULAR COMPLICATIONS COMPARED TO THE FEMORAL ARTERY ACCESS APPROACH—A KEY FACTOR DRIVING MARKET GROWTH 77
TABLE 31 RADIAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 77
TABLE 32 RADIAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 78
8 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE 79
8.1 INTRODUCTION 80
TABLE 33 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION) 80
TABLE 34 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 80
8.2 INTERVENTIONAL CARDIOLOGY 81
8.2.1 ASSOCIATED BENEFITS OF INTERVENTIONAL CARDIOLOGY PROCEDURES, SUCH AS REDUCED SCARRING AND LESS PAIN, TO DRIVE MARKET GROWTH 81
TABLE 35 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, BY REGION, 2017–2020 (USD MILLION) 82
TABLE 36 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, BY REGION, 2021–2026 (USD MILLION) 82
8.3 INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY 83
8.3.1 GROWTH IN THE PREVALENCE OF PAD IS INCREASING THE DEMAND FOR ENDOVASCULAR INTERVENTIONAL PROCEDURES 83
TABLE 37 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY PROCEDURES, BY REGION,
2017–2020 (USD MILLION) 83
TABLE 38 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY PROCEDURES, BY REGION,
2021–2026 (USD MILLION) 84
9 VASCULAR CLOSURE DEVICES MARKET, BY REGION 85
9.1 INTRODUCTION 86
TABLE 39 VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 86
TABLE 40 VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 86
9.2 NORTH AMERICA 87
FIGURE 20 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET SNAPSHOT 88
TABLE 41 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 88
TABLE 42 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 89
TABLE 43 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION) 89
TABLE 44 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 89
TABLE 45 NORTH AMERICA: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 90
TABLE 46 NORTH AMERICA: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 90
TABLE 47 NORTH AMERICA: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 90
TABLE 48 NORTH AMERICA: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 91
TABLE 49 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017–2020 (USD MILLION) 91
TABLE 50 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021–2026 (USD MILLION) 91
TABLE 51 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION) 92
TABLE 52 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION) 92
9.2.1 US 92
9.2.1.1 The US dominates the North American vascular closure
devices market 92
TABLE 53 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, 2020 93
TABLE 54 US: KEY MACROINDICATORS 94
TABLE 55 US: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION) 94
TABLE 56 US: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 95
TABLE 57 US: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 95
TABLE 58 US: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 95
TABLE 59 US: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION) 96
TABLE 60 US: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION) 96
TABLE 61 US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION) 96
TABLE 62 US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION) 97
TABLE 63 US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION) 97
TABLE 64 US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 97
9.2.2 CANADA 98
9.2.2.1 Rising prevalence of target diseases to drive market growth 98
TABLE 65 CANADA: KEY MACROINDICATORS 98
TABLE 66 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION) 99
TABLE 67 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 99
TABLE 68 CANADA: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 99
TABLE 69 CANADA: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 100
TABLE 70 CANADA: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 100
TABLE 71 CANADA: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 100
TABLE 72 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION) 101
TABLE 73 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION) 101
TABLE 74 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION) 101
TABLE 75 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 102
9.3 EUROPE 102
TABLE 76 NUMBER OF SURGICAL PROCEDURES PER 100,000 POPULATION,
BY COUNTRY, 2018 102
TABLE 77 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 103
TABLE 78 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 103
TABLE 79 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION) 103
TABLE 80 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 104
TABLE 81 EUROPE: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 104
TABLE 82 EUROPE: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 104
TABLE 83 EUROPE: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 105
TABLE 84 EUROPE: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 105
TABLE 85 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION) 105
TABLE 86 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION) 106
TABLE 87 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION) 106
TABLE 88 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 106
9.3.1 E-3 107
9.3.1.1 Increase in number of radial procedures to boost the market demand 107
TABLE 89 GERMANY: KEY MACROINDICATORS 107
TABLE 90 UK: KEY MACROINDICATORS 108
TABLE 91 FRANCE: KEY MACROINDICATORS 109
TABLE 92 E-3: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION) 110
TABLE 93 E-3: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 110
TABLE 94 E-3: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 110
TABLE 95 E-3: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 111
TABLE 96 E-3: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017–2020 (USD MILLION) 111
TABLE 97 E-3: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021–2026 (USD MILLION) 111
TABLE 98 E-3: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION) 112
TABLE 99 E-3: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION) 112
TABLE 100 E-3: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION) 112
TABLE 101 E-3: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 113
9.3.2 REST OF EUROPE 113
TABLE 102 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 114
TABLE 103 ROE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION) 114
TABLE 104 ROE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 115
TABLE 105 ROE: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 115
TABLE 106 ROE: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 115
TABLE 107 ROE: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 116
TABLE 108 ROE: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 116
TABLE 109 ROE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION) 116
TABLE 110 ROE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION) 117
TABLE 111 ROE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION) 117
TABLE 112 ROE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 117
9.4 ASIA PACIFIC 118
9.4.1 INCREASING HEALTH EXPENDITURE TO DRIVE MARKET GROWTH IN APAC 118
FIGURE 21 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET SNAPSHOT 119
TABLE 113 CHINA: KEY MACROINDICATORS 120
TABLE 114 JAPAN: KEY MACROINDICATORS 121
TABLE 115 INDIA: KEY INDICATORS 122
TABLE 116 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION) 123
TABLE 117 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 123
TABLE 118 ASIA PACIFIC: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 123
TABLE 119 ASIA PACIFIC: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 124
TABLE 120 ASIA PACIFIC: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 124
TABLE 121 ASIA PACIFIC: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 124
TABLE 122 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION) 125
TABLE 123 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION) 125
TABLE 124 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017–2020 (USD MILLION) 125
TABLE 125 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021–2026 (USD MILLION) 126
9.5 REST OF THE WORLD 126
9.5.1 GOVERNMENT INITIATIVES TO PROMOTE HEALTHCARE SERVICES TO SUPPORT MARKET GROWTH 126
TABLE 126 ROW: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2017–2020 (USD MILLION) 127
TABLE 127 ROW: VASCULAR CLOSURE DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 127
TABLE 128 ROW: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 128
TABLE 129 ROW: PASSIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 128
TABLE 130 ROW: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2017–2020 (USD MILLION) 128
TABLE 131 ROW: ACTIVE APPROXIMATORS MARKET, BY TYPE,
2021–2026 (USD MILLION) 129
TABLE 132 ROW: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2017–2020 (USD MILLION) 129
TABLE 133 ROW: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS,
2021–2026 (USD MILLION) 129
TABLE 134 ROW: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2017–2020 (USD MILLION) 130
TABLE 135 ROW: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 130
10 COMPETITIVE LANDSCAPE 131
10.1 OVERVIEW 131
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 131
TABLE 136 OVERVIEW OF STRATEGIES ADOPTED BY KEY VASCULAR CLOSURE DEVICES MARKET PLAYERS 131
10.3 REVENUE SHARE ANALYSIS 132
FIGURE 22 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN THE VASCULAR CLOSURE DEVICES MARKET 132
10.4 MARKET SHARE ANALYSIS 133
FIGURE 23 VASCULAR CLOSURE DEVICES MARKET SHARE ANALYSIS, 2020 133
TABLE 137 VASCULAR CLOSURE DEVICES MARKET: DEGREE OF COMPETITION (2020) 134

10.5 COMPANY EVALUATION QUADRANT 135
10.5.1 STARS 135
10.5.2 EMERGING LEADERS 135
10.5.3 PERVASIVE PLAYERS 135
10.5.4 PARTICIPANTS 135
FIGURE 24 VASCULAR CLOSURE DEVICES MARKET: COMPANY EVALUATION
QUADRANT (2020) 136
10.6 COMPANY EVALUATION QUADRANT: SMES/START-UPS 137
10.6.1 PROGRESSIVE COMPANIES 137
10.6.2 STARTING BLOCKS 137
10.6.3 RESPONSIVE COMPANIES 137
10.6.4 DYNAMIC COMPANIES 137
FIGURE 25 VASCULAR CLOSURE DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS (2020) 138
10.7 COMPETITIVE SCENARIO 139
10.7.1 PRODUCT LAUNCHES & APPROVALS 139
TABLE 138 PRODUCT LAUNCHES & APPROVALS 139
10.7.2 DEALS 140
TABLE 139 DEALS 140
10.7.3 OTHER DEVELOPMENTS 141
TABLE 140 OTHER DEVELOPMENTS 141
11 COMPANY PROFILES 142
11.1 KEY PLAYERS 142
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 TERUMO CORPORATION 142
TABLE 141 TERUMO CORPORATION: BUSINESS OVERVIEW 142
FIGURE 26 TERUMO CORPORATION: COMPANY SNAPSHOT (2020) 143
TABLE 142 EXCHANGE RATES (USED FOR THE CONVERSION OF YEN TO USD) 143
11.1.2 ABBOTT LABORATORIES 145
TABLE 143 ABBOTT LABORATORIES: BUSINESS OVERVIEW 145
FIGURE 27 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020) 146
11.1.3 CARDINAL HEALTH 148
TABLE 144 CARDINAL HEALTH: BUSINESS OVERVIEW 148
FIGURE 28 CARDINAL HEALTH: COMPANY SNAPSHOT (2021) 149
11.1.4 CARDIVA MEDICAL, INC. 151
TABLE 145 CARDIVA MEDICAL, INC.: BUSINESS OVERVIEW 151
11.1.5 MEDTRONIC PLC 153
TABLE 146 MEDTRONIC PLC: BUSINESS OVERVIEW 153
FIGURE 29 MEDTRONIC PLC: COMPANY SNAPSHOT (2021) 154
11.1.6 MORRIS INNOVATIVE, INC. 156
TABLE 147 MORRIS INNOVATIVE, INC.: BUSINESS OVERVIEW 156
11.1.7 TELEFLEX INCORPORATED 157
TABLE 148 TELEFLEX INCORPORATED: BUSINESS OVERVIEW 157
FIGURE 30 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020) 158
11.1.8 MERIT MEDICAL SYSTEMS, INC. 160
TABLE 149 MERIT MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW 160
FIGURE 31 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2020) 161
11.1.9 VASORUM LTD. 163
TABLE 150 VASORUM LTD.: BUSINESS OVERVIEW 163
11.1.10 TZ MEDICAL, INC. 165
TABLE 151 TZ MEDICAL INC.: BUSINESS OVERVIEW 165
11.2 OTHER PLAYERS 166
11.2.1 VIVASURE MEDICAL LTD. 166
11.2.2 TRICOL BIOMEDICAL 167
11.2.3 SCION BIOMEDICAL 168
11.2.4 ADVANCED VASCULAR DYNAMICS 169
11.2.5 MARINE POLYMER TECHNOLOGIES, INC. 170
11.2.6 TRANSLUMINAL TECHNOLOGIES 171
11.2.7 REX MEDICAL 172
11.2.8 MERIL LIFE SCIENCES PVT. LTD. 173
11.2.9 MEDAS USA 174
11.2.10 VYGON COMPANY 175
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 176
12.1 INSIGHTS FROM INDUSTRY EXPERTS 176
12.2 DISCUSSION GUIDE 177
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 180
12.4 AVAILABLE CUSTOMIZATIONS 182
12.5 RELATED REPORTS 182
12.6 AUTHOR DETAILS 183